PROSPECTIVE EVALUATION OF PATIENT-CENTERED CARE IN SHORT-TERM CANCER SURVIVORS, AT ONE AND TWO YEARS POST TREATMENT, THROUGH THE PATIENT ASSESSMENT OF CHRONIC ILLNESS CARE QUESTIONNAIRE.
Author(s)
Escobar A1, Bilbao A2, Perez-Ruiz E3, Rueda A4, Trujillo-Martin Md5
1Hospital Universitario Basurto. REDISSEC, Bilbao, Spain, 2Research Unit, Basurto University Hospital (Osakidetza) – Health Service Research Network on Chronic Diseases (REDISSEC), Bilbao, Spain, 3. Agencia Sanitaria Costa del Sol. Marbella. REDISSEC, Marbella, Malaga, Spain, 4Agencia Sanitaria Costa del Sol. REDISSEC, Marbella, Spain, 5Servicio de Evaluación y Planificación. REDISSEC, Tenerife, Spain
OBJECTIVES: The Chronic Care Model (CCM) is an accepted framework for delivering care to patients with chronic illnesses. The Patient Assessment of Chronic Illness Care (PACIC) is a questionnaire designed to assess the CCM from the patient´s perspective. Our aim was to document if patient´s assessment of chronic illness care changed at two time points. PACIC has been validated in Spanish METHODS: This prospective study included patients with colo-rectal (CCR), breast or prostate cancer. PACIC was administered by mail at 1-year and 2-years after finishing treatment. Questionnaire has 5 subscales, patient activation (PA), delivery system design (DSD), goal setting (GS), problem solving (PS) and follow-up coordination (FU). In addition there is a global score (G). Each subscale and the global are scored from 1 to 5 with higher scores indicating patient´s perception of greater involvement in self- management and receipt of chronic care counseling. Data are expressed as mean change (standard deviation of change). Comparison amongst two times was performed through non-parametric Wilcoxon test. RESULTS: There were 477 patients included, 106 prostate, 251 breast and 120 with CCR. 1-year scores were: PA: 3.3 (1.3), DSD: 3.6 (1.2), GS: 2.8 (1.3), PS: 3.0 (1.5), FU: 2.3 (1.3) and G: 2.9 (1.1). The mean change (SD) by dimensions were: PA: 0.1 (1.3), DSD: 0.11 (1.2), GS: 0.1 (1.1), PS: 0.09 (1.3), FU: 0.01 (1.1) and global: 0.07 (0.9). There were no statistically significant differences amongst both follow-up periods in any dimension, but DSD. However the effect size of this change was as small as 0.09 (mean change divided by SD of change). CONCLUSIONS: Based on these data the patient´s assessment of chronic illness care in these short-term cancer survivors does not change along the first two years of follow-up.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PHS149
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Quality of Care Measurement
Disease
Oncology